Epidemiology and Genetic Diversity of Human Metapneumovirus in Patients with Severe Acute Respiratory Infection from 2023 to 2024 in Ningxia, China

2023年至2024年中国宁夏地区重症急性呼吸道感染患者中人偏肺病毒的流行病学和遗传多样性

阅读:1

Abstract

BACKGROUND: Human metapneumovirus (HMPV) is a major pathogen responsible for causing severe acute respiratory infections (SARI). Whole-genome sequencing can better identify transmission events and outbreaks. In this study, we aimed to investigate the epidemiology and genetic diversity of HMPV in SARI cases in Ningxia, China. METHODS: We collected respiratory tract samples from hospitalized patients with SARI from October 2023 to September 2024 in Ningxia, China. Nasopharyngeal swabs were tested for respiratory viruses with qRT-PCR. Whole-genome sequences were determined for samples with high viral loads using an amplicon-based method. RESULTS: We enrolled 2873 SARI patients from October 2023 to September 2024, and found an HMPV-positive proportion of 3.06% (88/2873). Children aged 4 years were particularly susceptible to HMPV infection, with a positive proportion of 10.92% (13/119). HMPV exhibits distinct seasonal characteristics, consistent with its established epidemiological pattern, with a peak incidence occurring during winter months. Sixteen complete HMPV genome sequences were obtained. Among these, 81.25% (13/16) were identified as genotype A (A2.2.2: 92.31%, 12/13; A2.2.1: 7.69%, 1/13) and 18.75% (3/16) as genotype B1. Notably, the dominant strain was 111nt-dup in genotype A2.2.2. Sequence analysis of HMPV genes revealed divergent G-gene sequence identities between different genotypes. Additionally, the potential glycosylation sites of the G protein varied across genotypes. CONCLUSIONS: In this study, we found that the 111nt-dup strain was the dominant one in genotype A, and multiple genotypes co-circulated in Ningxia from October 2023 to September 2024. The HMPV G protein exhibited the highest level of inter-strain diversity between genotypes. These findings provide valuable insights into the prevention and control of HMPV infections in China.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。